Figure 4.
Changes in SUV imaging for 18F-FDG PET/CT and thoracolumbar spine metastases at different times (1 week prior to chemotherapy, 1 week after the first cycle of chemotherapy and two years post chemotherapy) prior to and following chemotherapy. SUV of 18F-FDG PET/CT imaging of baseline metastases (A) prior to chemotherapy, (B) subsequent to the first chemotherapy cycle and (C) two years following chemotherapy. Changes in SUV imaging of 18F-FDG PET/CT and liver metastases at different times prior to and following chemotherapy. SUV of 18F-FDG PET/CT imaging of baseline metastases (D) prior to chemotherapy, (E) subsequent to the first chemotherapy cycle and (F) two years following chemotherapy. 18F-FDG PET/CT, fluorine-18 fludeoxyglucose positron emission tomography-computed tomography; SUV, standardized uptake value.